Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Altimmune Inc (GB:0A4C)
LSE:0A4C
Altimmune (0A4C) Financial Statements
0 Followers
Altimmune Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 21.00K | $ -110.00K | $ 2.00K | $ 8.00K | $ 32.00K |
| Gross Profit | $ 21.00K | $ -110.00K | - | - | - |
| EBIT | $ -21.74M | $ -23.31M | $ -23.65M | $ -20.04M | $ -19.37M |
| EBITDA | $ -21.74M | $ -23.34M | $ -23.65M | $ -19.99M | $ -19.25M |
| Net Income Common Stockholders | $ -20.07M | $ -21.66M | $ -23.52M | $ -20.11M | $ -19.43M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 165.76M | $ 184.91M | $ 201.83M | $ 184.76M | $ 179.95M |
| Total Assets | $ 187.08M | $ 206.93M | $ 225.28M | $ 209.91M | $ 205.66M |
| Total Debt | $ 4.40M | $ 4.58M | $ 1.23M | $ 1.33M | $ 1.44M |
| Net Debt | $ -161.36M | $ -180.33M | $ -200.60M | $ -183.42M | $ -178.51M |
| Total Liabilities | $ 19.35M | $ 21.64M | $ 20.25M | $ 15.37M | $ 20.79M |
| Stockholders Equity | $ 167.73M | $ 185.29M | $ 205.03M | $ 194.53M | $ 184.87M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -19.46M | $ -17.34M | $ -15.11M | $ -16.72M | $ -13.54M |
| Operating Cash Flow | $ -19.41M | $ -17.31M | $ -15.05M | $ -16.70M | $ -13.53M |
| Investing Cash Flow | $ 13.30M | $ 981.00K | $ -25.40M | $ -48.97M | $ -9.00K |
| Financing Cash Flow | $ -302.00K | $ -43.00K | $ 32.06M | $ 21.58M | $ 3.18M |